The Data for (and Against) Coronavirus Vaccine Booster Shots

Modest benefit, minimal risk

The COVID controversy du jour seems to center firmly around the booster shot.

Last week the Vaccine and Related Biological Products Advisory Committee at the FDA met to review data on the safety and efficacy of a potential third dose of the Pfizer vaccine.